As Chinese and foreign medical device providers target each other's established base, partnership opportunities emerge

Last month, Medtronic announced the opening of a research and development (R&D) center in Beijing, established in collaboration with Shandong Weigao Group. The center will oversee the production of orthopedic products that caters to the Chinese population. Following announcements by GE Healthcare an...

This item has been archived in line with our efforts to keep our content relevant and up to date for our readership. For further assistance, please contact your Customer Success Manager or email Thank you!

Related Research

Chinese government's enabling policies support biopesticides, emerging opportunities for the industry

News Commentary | August 09, 2021

The Chinese government released a series of enabling policies to support research and innovation to promote biopesticides. Some of the measures include providing subsidies for the purchase of plant protection machinery for the application of biopesticies for managing major crop pests. The focus has ... Not part of subscription